A Glimmer of Hope: Sacituzumab Tirumotecan Shows Promise for Urothelial Carcinoma Patients A New Dawn for Bladder Cancer Patients: Astellas & Pfizer's Combination Therapy Halves Mortality Risk A New Horizon in Bladder Cancer Treatment: J&J's Balversa Secures Full FDA Approval FDA Greenlights J&J's Groundbreaking Bladder Cancer Therapy, Offering New Hope